ArticleThe Journal of infectious diseases2026

First Report on Remdesivir Use for the Treatment of Respiratory Syncytial Virus in Five Allogeneic Hematopoietic Cell Transplant Recipients.

Denise J McCulloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.